Activist investor Bluebell Capital Partners has built a stake in Bayer AG (OTC: BAYRY) (OTC: BAYZF) and is pushing it to split up.
The activist has been speaking to Bayer’s supervisory board behind the scenes over the past few months.
Bluebell has accumulated an undisclosed holding and is seeking an overhaul of Bayer’s corporate governance, Bloomberg …
